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We have shown that the uniaxial cyclic tensile strain of magnitude 10% promotes and enhances osteogenesis of
human mesenchymal stem cells (hMSC) and human adipose-derived stem cells (hASC) from normal, non-
osteoporotic donors. In the present study, MSC from osteoporotic donors were analyzed for changes in mRNA
expression in response to 10% uniaxial tensile strain to identify potential mechanisms underlying the use of this
mechanical loading paradigm for prevention and treatment of osteoporosis. Human MSC isolated from three
female, postmenopausal osteoporotic donors were analyzed for their responses to mechanical loading using
microarray analysis of over 47,000 gene probes. Human MSC were seeded in three-dimensional collagen type I
constructs to mimic the organic extracellular matrix of bone and 10% uniaxial cyclic tensile strain was applied
to promote osteogenesis. Seventy-nine genes were shown to be regulated within hMSC from osteoporotic
donors in response to 10% cyclic tensile strain. Upregulation of six genes were further confirmed with real-
time RT-PCR: jun D proto-oncogene ( JUND) and plasminogen activator, urokinase receptor (PLAUR), two
genes identified as potential key molecules from network analysis; phosphoinositide-3-kinase, catalytic, delta
polypeptide (PIK3CD) and wingless-type MMTV integration site family, member 5B (WNT5B), two genes
with known importance in bone biology; and, PDZ and LIM domain 4 (PDLIM4) and vascular endothelial
growth factor A (VEGFA), two genes that we have previously shown are significantly regulated in hASC in
response to this mechanical stimulus. Function analysis indicated that 10% cyclic tensile strain induced ex-
pression of genes associated with cell movement, cell proliferation, and tissue development, including de-
velopment in musculoskeletal and cardiovascular systems. Our results demonstrate that hMSC from aged,
osteoporotic donors are capable of enhanced osteogenic differentiation in response to 10% cyclic tensile strain
with significant increases in the expression of genes associated with enhanced cell proliferation, musculo-
skeletal development, and angiogenesis. Surprisingly, cyclic tensile strain of magnitude 10% not only en-
hanced osteogenesis in hMSC from osteoporotic donors, but also enhanced expression of angiogenic factors.
Better understanding and methodologies to promote osteogenesis in hMSC from elderly, osteoporotic donors
may greatly facilitate achieving long-term success in bone regeneration and functional bone tissue engineering
for this ever-growing patient population.
Introduction
Osteoporosis results in progressive bone loss and anincreased risk of bone fracture. Although typical treat-
ment involves the use of pharmacological agents to inhibit
bone resorption or increase bone mineral density,1 pharma-
cotherapy alone is not sufficient for the comprehensive
management of osteoporosis. Mechanical loading is also
critical for the maintenance of bone homeostasis.2 Regular
exercise has been shown to have a significant beneficial effect
in the treatment of osteoporosis.3
In general, mechanical loading regulates bone homeostasis
through its direct effects on bone formation and remodeling.
Bone responds to weight bearing by mineralization and to
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immobilization by demineralization.4,5 Immobilization in
plaster, bed rest, and/or weightlessness all result in calcium
loss and lead to disuse osteoporosis.4 However, actively
loaded bone exhibits increases in overall bone strength with
associated remodeling and increased bone mass.6,7
The dominant mechanical stimuli in bone include fluid
shear stress, compression, and tensile strain. Tensile strain
plays a key role in new bone regeneration during distraction
osteogenesis (DO), an induced bone formation process com-
monly performed for bone lengthening and the correction of
craniofacial deformities. We have previously shown in a me-
chanobiological study of mandibular DO that tensile stains at
magnitudes of 10–12.5% stimulate in vivo bone formation.8,9
Cyclic tensile strain of these magnitudes have also been found
to promote cell proliferation and upregulation of bone marker
genes in mesenchymal stem cells (MSC), osteoblasts, and
periosteal cells.10–12 Previous studies in our laboratory with
human MSC (hMSC) and human adipose-derived stem cells
(hASC) have further confirmed that 10% uniaxial cyclic tensile
strain enhances osteogenesis of these stem cells by increasing
bone markers and cell-mediated calcium accretion.13–15 It is
now accepted that proper mechanical stimulation can induce
proliferation and differentiation of bone precursor cells re-
sulting in an increase in bone formation and bone mass.16
MSC are precursor cells for bone formation and their lin-
eage specification is directly impacted by the mechanical
forces to which they are exposed.17,18 We have previously
shown that during osteogenic differentiation of hASC, 10%
uniaxial cyclic tensile strain increases osteogenesis and cau-
ses upregulation of proinflammatory cytokine regulators and
angiogenic factors.19 In this study, MSC isolated from aged,
postmenopausal osteoporotic donors were cultured in three-
dimensional (3D) collagen constructs and analyzed for
changes in mRNA expression in response to 10% uniaxial
cyclic tensile strain to attempt to identify potential mecha-
nisms underlying the use of appropriate mechanical loading
for prevention and treatment of osteoporosis.
We hypothesized that 10% cyclic tensile strain would en-
hance osteogenic differentiation of hMSC from osteoporotic
donors. We further hypothesized that the results of our mi-
croarray analysis would indicate that this process occurred
through some of the same signaling pathways found to be
regulated during the process of bone formation and also
through other distinct signaling molecules such as PDZ and
LIM domain 4 (PDLIM4), jun D proto-oncogene ( JUND), and
vascular endothelial growth factor A (VEGFA) that have not
been previously studied in the context of bone formation, but
which we have shown regulate hASC osteogenesis during
10% cyclic tensile strain.19
Materials and Methods
Cell isolation, culture, and characterization
Excess human bone fragments were obtained from three
age-matched female postmenopausal osteoporotic donors
undergoing elective orthopedic surgery (two 78-year-old and
one 95-year-old Caucasian female donors) in accordance
with an approved IRB protocol at University of North
Carolina (UNC)-Chapel Hill (IRB 04:1622). Human MSC
were isolated from the tissue using a method based on en-
zymatic digestion and substrate adherence, as previously
described.20 Briefly, bone fragments were washed thor-
oughly with phosphate-buffered saline (PBS) containing 1%
penicillin/streptomycin to remove all nonadherent hemato-
poietic cells. The fragments were diced into small pieces,
then digested in a collagenase XI solution (3 mg/mL Col-
lagenase Type XI-S in an a-modified essential medium
[aMEM]) at 37C for 3 h. Cells were then filtered through a
100-mm cell strainer, centrifuged at 500 g for 5 min, and
plated in T-75 flasks in a complete growth medium: aMEM
containing 10% fetal bovine serum (FBS; Atlanta Biologicals;
lot selected), 2 mM L-glutamine, 100 units/mL penicillin,
100 mg/mL streptomycin. After 24 h, the nonadherent cells
were washed out. Human MSC were then characterized by
their ability to differentiate down osteogenic and adipogenic
pathways as previously described.20,21 All cell culture che-
micals and supplies were purchased from Mediatech, Inc.
and Gibco BRL unless otherwise noted.
Osteogenic differentiation and calcium profile
To confirm the osteogenic differentiation ability of hMSC
from osteoporotic donors, cells were cultured in static
monolayer in 12-well plates with either the nondifferentiat-
ing growth medium or the osteogenic medium for 14 days.
The osteogenic medium consisted of the complete growth
medium plus osteogenic growth supplements comprised
50 mM ascorbic acid, 0.1 mM dexamethasone, and 10 mM b-
glycerophosphate. After 14 days, osteogenic differentiation
was determined by the endogenous alkaline phosphatase
(EALP) activity and the deposition of a mineralized matrix.
For the EALP activity, cell monolayers were washed twice
with PBS and fixed using 10% formalin for 15 min. The cell
membranes were then permeabilized by incubating in 0.2%
Triton X-100/0.5% bovine serum albumin in PBS for 10 min.
Subsequently, cell monolayers were rinsed again in PBS and
EALP was detected by incubating in 20 mL of 20-fold diluted
alkaline phosphatase substrate (ELF 97; Molecular Probes)
for 15 min. The phosphatase reaction was subsequently
stopped by adding 5 mM Levamisol and 25 mM EDTA
(Sigma) in PBS (wash buffer).
Deposition of the mineralized matrix was visualized with
Alizarin Red staining. In brief, cell monolayers were rinsed
with PBS, fixed with 10% formalin for 30 min, rinsed twice in
PBS, and stained with 2% Alizarin Red S.
Cell-mediated calcium accretion of hMSC from the three
osteoporotic donors was evaluated on day 14 and compared
with cell-mediated calcium accretion by hMSC from two
young, nonosteoporotic female donors, ages 19 and 25. Cell
monolayers were rinsed twice with PBS, then scraped out in
0.5 N HCl. Calcium was dissolved overnight at 4C and the
supernatant analyzed with a colorimetric Calcium LiquiCo-
lor assay (Stanbio Laboratory). Calcium accretion was then
normalized to cellular protein quantity (micro BCA protein
assay; Pierce). The proliferation rate, based on the metabolic
activity of the hMSC, was assessed using the Alamar Blue
assay (AbD Serotec) at days 1, 3, 6, and 9.
Fabrication of collagen gels
Human MSC were seeded into 3D collagen gels consisting
of 70% type I collagen (BD Biosciences) (pH adjusted to 7.0),
20% 5 · MEM, and 10% FBS at 60,000 cells/200 mL gel
solution. Linear 3D collagen constructs were created by
loading the cell-seeded gel solutions into Tissue Train
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collagen I-coated six-well culture plates (Flexcell Interna-
tional). Constructs were allowed to polymerize for 2 h before
addition of the complete growth medium.
Application of cyclic tensile strain
Twenty-four hours after cell seeding in the collagen gels,
cell-seeded constructs were cultured for an additional 2 weeks
in growth media in the presence (experimental) and/or ab-
sence (control) of 10% uniaxial cyclic tensile strain. Cell-seeded
constructs were subjected to 14 days of 10% uniaxial tensile
strain at 1 Hz for 4 h/day using a computer-driven strain de-
vice (FX-4000T; Flexcell International). Constructs were col-
lected on day 14 of treatment for RT-PCR and microarray
analyses. Constructs were washed twice in PBS, removed from
their anchors, placed in a lysis buffer containing b-mercap-
toethanol, and frozen at - 80C until RNA could be isolated.
RNA isolation and real-time RT-PCR analysis
Constructs were thawed on ice, ground with a mini-pestle,
and homogenized using a QIAshedder (Qiagen). Total RNA
was then purified using Eppendorf Perfect RNA mini-
columns according to the manufacturer’s recommended
protocol for eukaryotic cells. For microarray analysis, total
RNA was quantitated using a microplate-based RiboGreen
method (Molecular Probes).
Quantification of total RNA for PCR analysis was per-
formed with a Nanodrop system (Thermo-Fisher Scientific).
One hundred nanograms of each RNA sample was reverse
transcribed into cDNA using SuperScript III (Invitrogen)
with oligo dT primers. Real-time PCR was performed using
an ABI Prism 7000 Sequence Detection System (Applied
Biosystems). Based on findings from the microarray analy-
ses, six genes were selected for further confirmation of ex-
pression using real-time RT-PCR. Two genes were selected
from potential key molecules identified through network
analysis, two genes were selected based on the canonical
pathway and their potential role in bone biology, and the
final two genes were selected based on their similar expres-
sion in a previous study in hASC.19 TaqMan-based PCR
Assays-on-Demand (Applied Biosystems) were used for
further confirmation of mRNA expression of JUND, plas-
minogen activator, urokinase receptor (PLAUR), wingless-
type MMTV integration site family, member 5B (WNT5B),
phosphoinositide-3-kinase, catalytic, delta polypeptide
(PIK3CD), VEGFA, PDLIM 4, and glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), the endogenous control.
Expression levels were determined using the DDCT
method,22 and presented as a fold change from the mRNA
level in normal human adult bone tissue (BioChain), which
was set to 1.0. Real-time RT-PCR analyses were performed
for n = 3 donors with triplicate samples per condition. Data
were subjected to a two-tailed Student’s t-test to determine
significant difference ( p < 0.05) from control (unloaded, 0%
tensile strain). Data are presented as mean – standard error.
Biotin labeling, streptavidin antibody staining,
scanning, and detection
Gene expression analysis was conducted using Affymetrix
Human Genome U133 2.0 Genechip arrays (Affymetrix).
Total RNA was amplified using the Affymetrix 2-Cycle cDNA
Synthesis protocol. Starting with 20 ng of total RNA, cRNA
was produced according to the manufacturer’s protocol. For
each array, 15mg of amplified cRNAs were fragmented and
hybridized to the array for 16 h in a rotating hybridization
oven using the Affymetrix Eukaryotic Target Hybridization
Controls and protocol. Slides were stained and washed as
indicated in the Antibody Amplification Stain for Eukaryotic
Target protocol using the Affymetrix Fluidics Station FS450.
Arrays were then scanned with an Affymetrix Scanner 3000.
Data were obtained using the Genechip Operating Software
(Version 1.2.0.037). Microarray analyses were performed for
n = 3 donors (one sample per condition) on day 14.
Microarray data analysis
Data preprocessing, normalization, and error modeling
were performed with the Rosetta Resolver system (version
7.2.) (Rosetta Biosoftware). Principal Component Analysis
(PCA) was performed on all samples and all probes to
characterize any variability present in the data. Intensity
profiles were combined by weighted-averaging into Intensity
Experiments. When required, Intensity Experiments were
built into ratios representing treated/control (10% uniaxial
cyclic tensile strain compared to unloaded, 0% tensile strain),
as described by Stoughton and Dai.23 An error-weighted
ANOVA with the Bonferroni test was used to reduce the
number of false positives with p < 0.01.
Whole genome expression data were visualized in the
context of molecular function, canonical pathways, and bio-
logical network using the Ingenuity Pathway Analysis (IPA)
system (version 8.0) (Ingenuity Systems; www.ingenuity.com).
Data sets containing gene identifiers and corresponding ex-
pression values were uploaded into the application. Each gene
identifier was mapped to its corresponding gene. In the case of
genes with multi-identifiers, the highest expression value was
selected. The function and pathway analysis of IPA was gen-
erated based on all publicly available, published knowledge to
identify potential regulatory pathways and molecules.
Results
Proliferation and osteogenic differentiation of hMSC
from postmenopausal Caucasian osteoporotic donors
Human MSC from three aged, postmenopausal female os-
teoporotic donors had been preselected for positive MSC
markers and capability for adipogenic and osteogenic differ-
entiation in 2D culture. All three selected cell lines were verified
to deposit mineral over an area spanning at least 50% of the
tissue culture well, determined by Alizarin Red staining (Fig.
1A, B) and expression of alkaline phosphatase (Fig. 1C, D).
To further evaluate osteogenic differentiation potential,
accreted calcium, protein content, and proliferation rate were
quantified and compared with hMSC from young, non-
osteoporotic donors. Relative to hMSC cultured in complete
growth media, calcium content was significantly ( p < 0.01)
increased by osteogenic media in all three osteoporotic do-
nors (Fig. 2). Interestingly, hMSC from the three osteoporotic
donors exhibited a significantly ( p < 0.05) higher calcium/
protein ratio than hMSC from young, nonosteoporotic do-
nors. However, the metabolic activity as determined by
alamar blue assay on days 3, 6, 9 showed that hMSC from
osteoporotic donors proliferated significantly ( p < 0.05) less
MECHANOBIOLOGY OF MSC FROM OSTEOPOROTIC DONORS 69
than hMSC from young donors during culture in both
growth media and osteogenic media in monolayer culture
(Fig. 3). These findings indicated that the ability of hMSC
from osteoporotic donors to be chemically induced to dif-
ferentiate down an osteogenic lineage is not less than hMSC
from young, nonosteoporotic donors. However, their pro-
liferation rate is diminished.
Function analysis of genes regulated by hMSC
in response to 10% uniaxial cyclic tensile strain
It has been shown that exercises associated with increased
bone loading increase the bone mineral content in post-
menopausal osteoporotic women over the age of 7024 and
that mechanical loading increases both hMSC proliferation
and osteogenic differentiation.10,16,25–27 Therefore, we further
investigated how mechanical loading in the form of 10%
uniaxial cyclic tensile strain would regulate expression of
genes involved with proliferation and/or osteogenic differ-
entiation of hMSC from osteoporotic donors when hMSC
were seeded in 3D collagen I culture. A full microarray
analysis with 47,000 transcripts was implemented.
To identify the effect of 10% cyclic tensile strain on hMSC
from osteoporotic donors, the gene expression profiles of hMSC
cultured in complete growth media in the presence of strain
were compared to gene expression profiles of hMSC cultured in
growth media in the absence of mechanical load (0% strain).
Seventy three transcripts were modulated by strain, which
mapped to 68 genes with IPA (Supplementary Table S1 Sup-
plementary Data are available online at www.liebertpub.com/
tea). Sixty-two genes were eligible for network analysis and 57
genes were eligible for function analyses.
Cellular movement was the top molecular and cellular
function when categorizing the genes modulated by strain
(25 genes, p < 10 - 8–10 - 3). Major subfunctions included in-
vasion of cells, cell movement, chemotaxis, and cell migra-
tion with upregulation of 23 genes, including transcription
regulators JUND, basic helix-loop-helix family, member e40
(BHLHE40), H2.0-like homeobox (HLX), plasma membrane
receptor PLAUR, insulin-like growth factor 1 receptor
(IGF1R), actin binding FXYD domain containing ion trans-
port regulator 5 (FXYD5), and ezrin (EZR) (Fig. 4A and
Supplementary Table S2).
Tumor morphology was ranked first when categorizing the
genes modulated by strain in physiological system develop-
ment and function (8 genes, p < 10- 7–10 - 3) with major sub-
functions of tumor progression and vascularization (Fig. 4B
and Supplementary Table S3). The second ranked physiologi-
cal system development and function was tissue development
with 32 differentially expressed genes involved ( p < 10 - 6–10- 3)
FIG. 1. Human mesenchymal stem
cells (hMSC) from three aged, post-
menopausal female osteoporotic do-
nors are able to osteogenically
differentiate after chemical stimula-
tion in osteogenic induction media for
14 days in 2D monolayer culture.
Alizarin Red staining for calcium ac-
cretion (A) in growth media or (B)
osteogenic media. Endogenous alka-
line phosphatase (EALP) activity of
hMSC after 14 days (C) in growth
media or (D) in osteogenic induction
media. EALP activity indicated in
bright green; nuclei shown in blue.
Color images available online at
www.liebertpub.com/tea
FIG. 2. Quantitative analysis of cell-mediated calcium ac-
cretion normalized to cellular protein content after 14 days of
hMSC culture in the complete growth medium (CGM) or the
osteogenic medium (ODM). hMSC isolated from osteopo-
rotic donors (A, B, C) exhibited a significantly (*p < 0.05,
**p < 0.01) higher calcium/protein ratio than hMSC isolated
from young, nonosteoporotic donors (D, E).
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with the subfunctions of tissue formation, adhesion, develop-
ment, morphology, and angiogenesis in multiple tissues. Three
specific physiological systems also ranked in the top ten of
development and function that were differentially expressed
by hMSC in response to strain were (1) digestive system (10
genes, p < 10- 6–10- 3) with genes involved with morphology
and development of tooth, (2) skeletal and muscular system (20
genes, p < 10- 5–10 - 3) with genes involved with development
and formation of muscle and bone, and (3) cardiovascular
system (14 genes, p < 10- 5–10- 3) with genes involved with
angiogenesis, neovascularization, and development of blood
vessels (Fig. 4B and Supplementary Table S3).
Network analysis and canonical pathway of genes
regulated by hMSC in response to 10% uniaxial cyclic
tensile strain
The first ranked network was associated with cellular
movement, cell morphology, and skeletal and muscular
system development and function. This network had a score
of 52 (scores of 2 or higher have at least a 99% confidence of
not being generated by random chance alone) with 22 fo-
cused genes and 37 total genes in the network (Fig. 5A and
Supplementary Table S4). Five focused molecules, JUND,
tumor necrosis factor receptor superfamily, member 12A
(TNFRSF12A), follistatin (FST), PLAU, and PLAUR, were
located in the center of the network and linked with four or
more other molecules. The second ranked network was as-
sociated with cardiovascular disease, tissue morphology,
and molecular transport with a score of 42 and 19 focused
genes. In contrast to the first ranked network, centered genes
in this network were not expressed by hMSC in response to
strain at day 14 (Fig. 5B). The biggest group of genes was
directly linked with ubiquitin C (UBC), including upregula-
tion of PDLIM4, zinc finger protein 281 (ZNF281), uridine-
cytidine kinase 2 (UCK2), sphinganine-1-phosphate aldolase
(SGPL1), FXYD domain containing ion transport regulator 5
(FXYD 5), and MICAL-like 1 (MICALL1).
Pathway analysis indicated that relatively few genes (20 of
68 genes) that were modulated in response to strain by
hMSC were significantly mapped in the canonical pathways
(supplementary Table S5). Interestingly, five of the genes
(metalloproteinases BMP1, receptor binding WNT5B, protein
binding PIK3CD, transcription factor TCF4, and receptor
FZD8) were found to be repeatedly associated and mapped
in multiple top ten pathways (Fig. 6).
Real-time RT-PCR analysis of selected differentially
expressed genes identified by cDNA microarray
To confirm the expression data from the microarray ana-
lyses, six genes upregulated by hMSC in response to strain as
detected by microarray were also validated with quantitative
RT-PCR analysis. Genes were chosen based on the statistical
significance of the differential expression of a gene as de-
tected by microarray (i.e., the error-weighted ANOVA with
the Bonferroni test p < 0.01) and also their potential functional
relevance to bone metabolism and/or potential key mole-
cules expressed by hMSC in response to mechanical loading
from pathway, network, and function analyses. Two of the
selected genes were centered in the first rank network:
JUND, a member of activator protein-1 (AP-1), shown to be a
controlling molecule in bone formation, osteoblast prolifer-
ation, and osteoblast differentiation,28–31 and PLAUR, shown
to be involved in bone homeostasis and bone formation.32,33
PIK3CD and WNT5B were both mapped together with the
top five canonical pathways (Fig. 6). PIK3CD, a gene en-
coding for a catalytic subunit of p110, has been found to be
upregulated during bone fracture repair34 and to play an
important role in osteoblast differentiation.35 PDLIM4 was
one of the top ten upregulated genes in our data set and has
previously been shown to have polymorphisms found to
associate with bone mineral density regulation.36,37 VEGFA
is an angiogenic factor. We have previously reported that
both VEGFA and PDLIM4 are upregulated by hASC during
osteogenesis in response to 10% uniaxial cyclic tensile
strain.19 RT-PCR results confirmed that expression of all
genes was significantly increased in hMSC in response to
10% uniaxial cyclic tensile strain (Fig. 7).
Discussion
Human MSC hold great promise for their use in cell-based
therapy for a number of degenerative conditions. Whereas
FIG. 3. Comparative analysis of average proliferation rate (normalized to day 1) of hMSC isolated from osteopotic donors
(OP) and hMSC isolated from young, nonosteoporotic donors (Y) in the complete growth medium (A) or the osteogenic
medium (B) on days 3, 6, and 9 in 2D monolayer culture. Proliferation of hMSC from osteoporotic donors is significantly
(*p < 0.05) less than hMSC from nonosteoporotic donors at all time points in both growth and osteogenic differentiation media.
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many previous studies have been performed on the use of
MSC for tissue engineering and shown their promise for
regeneration of multiple tissues,38–43 only a limited amount
of research has focused on hMSC from aged donors who
more typically suffer from degenerative diseases. In the
present study, hMSC from aged, postmenopausal osteopo-
rotic donors were analyzed using microarray analysis to
determine potential mechanobiological mechanisms associ-
ated with enhanced osteogenic differentiation of hMSC
from osteoporotic donors. Collagen type I was used to mimic
the organic extracellular matrix (ECM) of bone and 10%
uniaxial cyclic tensile strain was applied as an appropriate
mechanical load to promote osteogenesis.13–15,19,44 Micro-
array analysis with over 30,000 gene probes was utilized for
global analysis to obtain insight into associated regulatory
mechanisms.
FIG. 4. Function analysis indicates that 10% uniaxial cyclic tensile strain induces expression of genes associated with cellular
movement, growth, and proliferation in hMSC from osteoporotic donors as shown in the top ten molecular and cellular
functions (A); and the expression of genes associated with system development and function for skeletal, muscular, and
cardiovascular systems as shown in the top ten categories expressed within physiological and system development and
function (B). Left Y-axis is - log ( p-value) shown as bar chart. Right Y-axis is number of genes associated with functions
shown as dot (.) with number.
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We found that hMSC from aged, osteoporotic donors ex-
hibit a significant decrease in the proliferation rate compared
to hMSC from young, nonosteoporotic donors. These find-
ings are consistent with previous investigators who have
shown that hMSC progenitor cell numbers are reduced with
aging.45 However, the hMSC from osteoporotic donors were
able to differentiate down an osteogenic pathway when
chemically induced with a medium that included osteogenic
supplements consisting of ascorbic acid, dexamethasone, and
b-glycerophosphate, to a greater extent on a per cell basis
than hMSC from young donors. Initially, one might infer that
this result could occur through use of isolated hMSC, which
were preinduced in vivo with pharmacotherapy for osteo-
porosis; however, the selected donors chosen for this study
had no history of osteoporosis pharmacotherapy treatment.
Previous studies on the effects of aging on osteogenic dif-
ferentiation of hMSC have reported contradictory results
depending on grouping and different conditions of the
FIG. 5. Potential key molecules af-
fected in hMSC from osteoporotic do-
nors in response to 10% uniaxial cyclic
tensile strain are jun D proto-oncogene
( JUND), plasminogen activator, uro-
kinase (PLAU), plasminogen activator,
urokinase receptor (PLAUR), vascular
endothelial growth factor A (VEGFA),
and follistatin (FST) as centered in the
first (A), and ubiquitin C (UBC) as
centered in the second (B) ranked
networks (highlighted with blue cir-
cles). The first ranked network was
generated with 22 focus genes previ-
ously found to be associated to cellular
movement, cell morphology, and
skeletal and muscular system devel-
opment and function (A). The second
ranked network was generated with
19 focus genes previously found to be
associated with tissue morphology,
cardiovascular disease, and molecular
transport (B). Red indicates upregu-
lated molecules; green indicates
downregulated molecules. Color in-
tensity indicates the level of expres-
sion (see Supplementary Table S4 for
full names and expression profile
data). Color images available online at
www.liebertpub.com/tea
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donors.46–51 Therefore, in this study, we specifically com-
pared differentiation of hMSC from postmenopausal osteo-
porotic donors over the age of 60 who were not undergoing
any pharmacotherapy, to those of healthy, skeletally mature
females between the ages of 19–25.
One hundred eighty-four transcripts and 68 transcripts
that we previously found to be significantly modulated
by 10% cyclic tensile strain in hASC19 were also modulated
by hMSC from osteoporotic donors in response to this
mechanical stimulus. One might expect hMSC to have higher
sensitivity to mechanical loading than hASC as MSC are
direct progenitor cells in bone, a highly load bearing tissue.
However, a combination of the use of hASC from younger
donors as well as the additional induction by the osteogenic
differentiation medium utilized in the previous study might
have provided synergistic effects to further increase the
mechanosensitivity of hASC. This should be further explored
in future studies.
FIG. 6. Canonical pathways affected in hMSC from osteoporotic donors by 10% uniaxial cyclic tensile strain. Top 10 canonical
pathways showed that five genes (FZD8, TCF4, phosphoinositide-3-kinase, catalytic, delta polypeptide [PIK3CD], wingless-
type MMTV integration site family, member 5B [WNT5B], and BMP1) are associated and repeatedly mapped in multiple
pathways (A). Mapped canonical pathway, role of osteoblasts, osteoclasts, and chondrocytes in rheumatoid arthritis, showed
the integrated signals of these genes in Wnt/BMP/PIK signaling (B). Color images available online at www.liebertpub.com/tea
FIG. 7. RT-PCR results. Up-
regulation of six genes identi-
fied with microarray analysis:
JUND, PDZ and LIM domain
4 (PDLIM 4), PIK3CD,
PLAUR, VEGFA, and WNT5B
in hMSC from osteoporotic
donors in response to 10%
uniaxial cyclic tensile strain
had expression confirmed
with RT-PCR. Gene expres-
sion in growth media without
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Eight genes were significantly upregulated in both hASC
and hMSC by 10% cyclic tensile strain (Supplementary Table
S6). Similarities in mechanobiological responses included
upregulation of genes associated with functions such as cell
proliferation, cellular movement, and cardiovascular devel-
opment (Supplementary Fig. S1).
Function analysis showed an increase in genes associated
with cellular movement and proliferation of hMSC from
osteoporotic donors when exposed to 10% uniaxial cyclic
tensile strain in 3D collagen culture. Although relative pro-
liferation of hMSC in 3D collagen gels by cyclic tensile strain
was not monitored over time in this study, we observed a
higher yield of total RNA content in those hMSC-seeded
constructs that underwent mechanical loading (Supplemen-
tary Fig. S2). It has been shown that cell proliferation can be
promoted with appropriate mechanical loading both in vivo
and in vitro.52–55 Our results support these previous findings.
Whereas tumor morphology was ranked first for physiology
function, only 8 genes were associated with this function.
However, 32 genes were associated with the second ranked
tissue development function, and 20 genes were associated
with the seventh ranked skeletal and muscular system de-
velopment and function (Fig. 4B). The lower number of
mapped genes associated with tumor morphology likely
result from the low number of genes associated with this
function in the publicly available literature. These same 8
genes were subsets of tissue development and skeletal and
muscular system development. Therefore, to better identify
the potential function of consistently expressed genes, both
the number of mapped genes and the p-value for each
function were simultaneously considered for more accurate
analysis.
Physiological function showed not only an increase in
musculoskeletal development, but also an increase in car-
diovascular development by hMSC from osteoporotic do-
nors exposed to 10% cyclic tensile strain. We have previously
shown that 10% cyclic tensile strain promotes osteogenic
differentiation of hMSC and hASC in both 2D and 3D cul-
ture.13–15,19,44 Previous studies with human periodontal lig-
ament stem cells, preosteoblasts, and osteoblasts have also
reported that tensile strain induces osteogenesis and ECM
formation.56–58 We have also previously found that 10% cy-
clic tensile strain induces the upregulation of proin-
flammatory cytokine regulators: SOCS3 and IL1RN, and
angiogenic factors: FGF2, VEGFA, and MMP2 in hASC un-
dergoing osteogenic differentiation.19 Findings from the
current study indicate that upregulation of VEGF in response
to 10% cyclic tensile strain is consistent in both hASC and
hMSC. Our finding of enhanced angiogenic signaling by
MSC in response to specific mechanical stimulation is con-
sistent with other findings. It has been shown that with cyclic
tensile induction, MSC can promote angiogenesis by elevat-
ing proliferation of endothelial cells, potentially through
FGFR and VEGFR signaling.59 In a recent study with VEGF-
deficient mice and mice with VEGF receptor 1 or VEGF re-
ceptor 2 knockdown, it was shown that VEGF not only
played a role in angiogenesis, but also that intracellular
VEGF regulated the balance of osteoblast or adipocyte dif-
ferentiation in MSC.60 Whereas the focus of the present study
was on a complete microarray gene expression analysis of
MSC from osteoporotic donors in response to mechanical
load in the form of 10% cyclic tensile strain alone, future
studies examining the combination of osteogenic induction
media and cyclic tensile strain on MSC response would be
interesting to perform. Genes shown to be modulated in this
study could be further investigated as well as other genes of
interest in the context of bone formation or cellular function
in response to tensile strain, such as BHLHE40, HLX, IGF1R,
FXYD5, and EZR.
Interestingly, downregulation of FZD8 and upregulation
of WNT5B, TCF4, PIK3CD, and BMP1 in hMSC with 10%
uniaxial cyclic tensile strain were repeatedly associated to-
gether and mapped in multiple canonical pathways (Fig. 6).
FZD8, WNT5B, and TCF4 are members of the Wnt signaling
pathway. WNT5B and FZD8, a Wnt receptor-ligand complex,
have also been found to be modulated in different phases of
osteogenic differentiation of hMSC when chemically induced
in 2D monolayer culture.61 Downregulation of FZD8 and
upregulation of its inhibitor have also been shown to re-
spond as a feedback inhibition when Wnt signaling is up-
regulated in human embryonic stem cells.62 TCF4, one of the
nuclear effectors of Wnt signaling, represents a final target of
cellular control through Wnt-dependent growth and sur-
vival.63 Wnt signaling pathways have been found to be in-
tegrated together with BMP signaling and phosphoinositide
3-kinase-dependent signaling in stem cells’ self-
renewal and osteoblast differentiation.64–66 We have shown
here that BMP-1 (from BMP signaling), PIK3CD (from PIKs
signaling), and FZD8, WNT5B, and TCF4 (from Wnt signal-
ing) are modulated together in the response of hMSC from
osteoporotic donors to 10% uniaxial cyclic tensile strain as a
potential integration of Wnt/BMP/PIK signaling. Whereas
beyond the scope of this study, further investigation of these
signaling pathways in response to 10% cyclic tensile strain
should be performed to fully evaluate their independent and
integrated signaling mechanisms.
In summary, we have found that 10% cyclic tensile strain
enhances the modulation of genes associated with increases
in both proliferation and osteogenic differentiation of hMSC
from osteoporotic donors. The potential mechanisms include
the known canonical pathways that play an important role in
bone formation such as Wnt/BMPs/PIKs signaling and,
also, interestingly, through the process of angiogenesis and
neovascularization. This is the first study to investigate the
effect of both 3D collagen culture and 10% uniaxial cyclic
tensile strain on osteogenic differentiation of hMSC from
osteoporotic donors. A complete microarray analysis of the
expression of 47,000 genes with identifying potential key
genes and signaling was performed. The findings from this
study provide significant information and better under-
standing toward our use of hMSC from elderly, osteoporotic
donors for achieving long-term success in bone regeneration
and functional bone tissue engineering for this ever-growing
patient population.
Acknowledgments
This research was supported, in part, by the Intramural
Research Program of the NIH, National Institute of En-
vironmental Health Sciences, by the National Center for
Research. Resources grant 10KR51023 (E.G.L.), by NIH/
NIBIB grant R03EB008790 (E.G.L.), and by NSF/CBET
grant 1133427 (E.G.L.). Excess human bone fragments were
obtained from waste tissue from voluntary orthopedic
MECHANOBIOLOGY OF MSC FROM OSTEOPOROTIC DONORS 75
surgeries at the UNC-CH hospital. Cell isolation, culture,
mechanical loading, and PCR analysis were performed at the
North Carolina State University. Microarray imaging and
statistical analysis were performed at the National Institute
of Environmental Health Sciences, NIH.
Disclosure Statement
No competing financial interests exist.
References
1. Siris, E.S., Selby, P.L., Saag, K.G., Borgström, F., Herings, R.,
and Silverman, S.L. Impact of osteoporosis treatment ad-
herence on fracture rates in North America and Europe. Am
J Med 122, S3, 2009.
2. Sinaki, M., Pfeifer, M., Preisinger, E., Itoi, E., Rizzoli, R.,
Boonen, S., Geusens, P., and Minne, H.W. The role of exer-
cise in the treatment of osteoporosis. Curr Osteoporos Rep 8,
138, 2010.
3. Hurley, B., and Armstrong, T.J. Bisphosphonates vs exercise
for the prevention and treatment of osteoporosis. J Nurse
Pract 8, 217, 2012.
4. Leblanc, A.D., Schneider, V.S., Evans, H.J., Engelbretson,
D.A., and Krebs, J.M. Bone mineral loss and recovery after
17 weeks of bed rest. J Bone Miner Res 5, 843, 1990.
5. Wolff, I., Van Croonenborg, J., Kemper, H., Kostense, P., and
Twisk, J. The effect of exercise training programs on bone
mass: a meta-analysis of published controlled trials in pre-
and postmenopausal women. Osteoporos Int 9, 1, 1999.
6. Turner, C.H., and Robling, A.G. Designing exercise regimens
to increase bone strength. Exerc Sport Sci Rev 31, 45, 2003.
7. Robling, A.G., Castillo, A.B., and Turner, C.H. Biomechani-
cal and molecular regulation of bone remodeling. Annu Rev
Biomed Eng 8, 455, 2006.
8. Loboa, E.G., Fang, T.D., Parker, D.W., Warren, S.M., Fong,
K.D., Longaker, M.T., and Carter, D.R. Mechanobiology of
mandibular distraction osteogenesis: finite element analyses
with a rat model. J Orthop Res 23, 663, 2005.
9. Loboa, E.G., Fang, T.D., Warren, S.M., Lindsey, D.P., Fong,
K.D., Longaker, M.T., and Carter, D.R. Mechanobiology of
mandibular distraction osteogenesis: experimental analyses
with a rat model. Bone 34, 336, 2004.
10. Kanno, T., Takahashi, T., Ariyoshi, W., Tsujisawa, T., Haga,
M., and Nishihara, T. Tensile mechanical strain up-regulates
Runx2 and osteogenic factor expression in human periosteal
cells: implications for distraction osteogenesis. J Oral Max-
illofac Surg 63, 499, 2005.
11. Fong, K.D., Nacamuli, R.P., Loboa, E.G., Henderson, J.H.,
Fang, T.D., Song, H.M., Cowan, C.M., Warren, S.M., Carter,
D.R., and Longaker, M.T. Equibiaxial tensile strain affects
calvarial osteoblast biology. J Craniofac Surg 14, 348, 2003.
12. Koike, M., Shimokawa, H., Kanno, Z., Ohya, K., and Soma,
K. Effects of mechanical strain on proliferation and differ-
entiation of bone marrow stromal cell line ST2. J Bone Miner
Metab 23, 219, 2005.
13. Hanson, A.D., Marvel, S.W., Bernacki, S.H., Banes, A.J., van
Aalst, J., and Loboa, E.G. Osteogenic effects of rest inserted
and continuous cyclic tensile strain on hASC lines with
disparate osteodifferentiation capabilities. Ann Biomed Eng
37, 955, 2009.
14. Sumanasinghe, R.D., Bernacki, S.H., and Loboa, E.G. Os-
teogenic differentiation of human mesenchymal stem cells in
collagen matrices: effect of uniaxial cyclic tensile strain on
bone morphogenetic protein (BMP-2) mRNA expression.
Tissue Eng 12, 3459, 2006.
15. Wall, M.E., Rachlin, A., Otey, C.A., and Loboa, E.G. Human
adipose-derived adult stem cells upregulate palladin during
osteogenesis and in response to cyclic tensile strain. Am J
Physiol Cell Physiol 293, 2007.
16. Qi, M.C., Hu, J., Zou, S.J., Chen, H.Q., Zhou, H.X., and Han,
L.C. Mechanical strain induces osteogenic differentiation:
Cbfa1 and Ets-1 expression in stretched rat mesenchymal
stem cells. Int J Oral Maxillofac Surg 37, 453, 2008.
17. Turner, C.H., Forwood, M., Rho, J.Y., and Yoshikawa, T.
Mechanical loading thresholds for lamellar and woven bone
formation. J Bone Miner Res 9, 87, 1994.
18. Kelly, D., and Prendergast, P.J. Mechano-regulation of stem
cell differentiation and tissue regeneration in osteochondral
defects. J Biomech 38, 1413, 2005.
19. Charoenpanich, A., Wall, M.E., Tucker, C.J., Andrews,
D.M.K., Lalush, D.S., and Loboa, E.G. Microarray analysis of
human adipose-derived stem cells in three-dimensional
collagen culture: osteogenesis inhibits bone morphogenic
protein and Wnt signaling pathways, and cyclic tensile
strain causes upregulation of proinflammatory cytokine
regulators and angiogenic factors. Tissue Eng Part A 17,
2615, 2011.
20. Sakaguchi, Y., Sekiya, I., Yagishita, K., Ichinose, S., Shino-
miya, K., and Muneta, T. Suspended cells from trabecular
bone by collagenase digestion become virtually identical to
mesenchymal stem cells obtained from marrow aspirates.
Blood 104, 2728, 2004.
21. Wall, M.E., Bernacki, S.H., and Loboa, E.G. Effects of serial
passaging on the adipogenic and osteogenic differentiation
potential of adipose-derived human mesenchymal stem
cells. Tissue Eng 13, 1291, 2007.
22. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene
expression data using real-time quantitative PCR and the 2
CT method. Methods 25, 402, 2001.
23. Stoughton, R., and Dai, H. Statistical combining of cell ex-
pression profiles, U.S. Patent No 6,351,712, 2002.
24. Simkin, A., Ayalon, J., and Leichter, I. Increased trabecular
bone density due to bone-loading exercises in postmeno-
pausal osteoporotic women. Calcif Tissue Int 40, 59, 1987.
25. Rui, Y.F., Lui, P.P.Y., Ni, M., Chan, L.S., Lee, Y.W., and
Chan, K.M. Mechanical loading increased BMP-2 expression
which promoted osteogenic differentiation of tendon-
derived stem cells. J Orthop Res 29, 390, 2010.
26. Friedl, G., Schmidt, H., Rehak, I., Kostner, G., Schauenstein,
K., and Windhager, R. Undifferentiated human mesenchy-
mal stem cells (hMSCs) are highly sensitive to mechanical
strain: transcriptionally controlled early osteo-chondrogenic
response in vitro. Osteoarthritis Cartilage 15, 1293, 2007.
27. Li, Y.J., Batra, N.N., You, L., Meier, S.C., Coe, I.A., Yellow-
ley, C.E., and Jacobs, C.R. Oscillatory fluid flow affects hu-
man marrow stromal cell proliferation and differentiation. J
Orthop Res 22, 1283, 2004.
28. McCabe, L.R., Kockx, M., Lian, J., Stein, J., and Stein, G.
Selective expression of fos-and jun-related genes during os-
teoblast proliferation and differentiation. Exp Cell Res 218,
255, 1995.
29. Wagner, E. Functions of AP1 (Fos/Jun) in bone develop-
ment. Ann Rheumat Dis 61, ii40, 2002.
30. McCabe, L.R., Banerjee, C., Kundu, R., Harrison, R.J., Dob-
ner, P.R., Stein, J.L., Lian, J.B., and Stein, G.S. Developmental
expression and activities of specific fos and jun proteins
are functionally related to osteoblast maturation: role of
76 CHAROENPANICH ET AL.
Fra-2 and Jun D during differentiation. Endocrinology 137,
4398, 1996.
31. Yeo, H., Beck, L.H., McDonald, J.M., and Zayzafoon, M. Cy-
closporin A elicits dose-dependent biphasic effects on osteo-
blast differentiation and bone formation. Bone 40, 1502, 2007.
32. Furlan, F., Galbiati, C., Jorgensen, N.R., Jensen, J.E.B., Mrak,
E., Rubinacci, A., Talotta, F., Verde, P., and Blasi, F. Ur-
okinase plasminogen activator receptor affects bone ho-
meostasis by regulating osteoblast and osteoclast function. J
Bone Miner Res 22, 1387, 2007.
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